Khiron Life Sciences Corp (CVE:KHRN) (OTCMKTS:KHRNF) Medical Director Dr. Maria Arboleda shares the company’s three-pronged approach to the medical cannabis space in Colombia specifically and, more broadly, Latin American. Dr. Arboleda discusses Khiron’s role in training doctors in Latin America on the value of medical cannabis. Khiron is also developing specialized cannabis clinics based on the Canadian model but adapted to the specific needs and cultural beliefs of Colombians. Khiron plans to develop Colombian-based cannabis research to meet the information and research requirements of Invima, a national drug and food monitoring agency. This approach positions Khiron competitively in the region’s medical cannabis space, which it estimates at 48 million patients in Colombia and 620 million patients in Latin America.